Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of our current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics and gene therapy to the brain. The ClearPoint® Neuro Navigation System has FDA clearance, is CE-marked, and is installed in 60+ Clinical & Research Centers in the US, Canada, & EU... and growing globally. ClearPoint Neuro’s SmartFlow® cannula is being used in partnership or evaluation with 30+ individual biologics and drug delivery companies in various stages, from preclinical research to late stage regulatory trials. To date, more than 4,000 cases have been performed and supported by our field-based Clinical Specialist team which offers support and services for our partners.
Location: United States, California, Solana Beach
Employees: 51-200
Founded date: 1998
Investors 1
| Date | Name | Website |
| 12.07.2023 | Johns Hopk... | ventures.j... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 12.03.2024 | ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 R... | Release Includes Commentary on Early 2024 Progress SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSW... | einpresswi... |
| 09.01.2024 | Clinical Laserthermia Systems receives SEK 8.1 million order... | Clinical Laserthermia Systems receives SEK 8.1 million order from ClearPoint Neuro Tue, Jan 09, 2024... | news.cisio... |
| 16.05.2023 | Two additional ClearPoint™ Prism systems installed in the U.... | Two additional ClearPoint™ Prism systems installed in the U.S. Tue, May 16, 2023 08:00 CET Report th... | news.cisio... |
| 02.05.2023 | CLS announces enrollment completion of initial phase of CLS-... | CLS announces enrollment completion of initial phase of CLS-sponsored glioblastoma laser ablation st... | news.cisio... |